1. Home
  2. SLDB vs AXR Comparison

SLDB vs AXR Comparison

Compare SLDB & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • AXR
  • Stock Information
  • Founded
  • SLDB 2013
  • AXR 1961
  • Country
  • SLDB United States
  • AXR United States
  • Employees
  • SLDB N/A
  • AXR N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • AXR Homebuilding
  • Sector
  • SLDB Health Care
  • AXR Real Estate
  • Exchange
  • SLDB Nasdaq
  • AXR Nasdaq
  • Market Cap
  • SLDB 212.2M
  • AXR 188.7M
  • IPO Year
  • SLDB 2018
  • AXR N/A
  • Fundamental
  • Price
  • SLDB $4.85
  • AXR $32.89
  • Analyst Decision
  • SLDB Strong Buy
  • AXR
  • Analyst Count
  • SLDB 10
  • AXR 0
  • Target Price
  • SLDB $17.50
  • AXR N/A
  • AVG Volume (30 Days)
  • SLDB 295.0K
  • AXR 20.1K
  • Earning Date
  • SLDB 11-06-2024
  • AXR 12-09-2024
  • Dividend Yield
  • SLDB N/A
  • AXR N/A
  • EPS Growth
  • SLDB N/A
  • AXR N/A
  • EPS
  • SLDB N/A
  • AXR 1.76
  • Revenue
  • SLDB N/A
  • AXR $60,171,000.00
  • Revenue This Year
  • SLDB N/A
  • AXR N/A
  • Revenue Next Year
  • SLDB N/A
  • AXR N/A
  • P/E Ratio
  • SLDB N/A
  • AXR $18.41
  • Revenue Growth
  • SLDB N/A
  • AXR 24.69
  • 52 Week Low
  • SLDB $2.21
  • AXR $15.88
  • 52 Week High
  • SLDB $15.05
  • AXR $36.21
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 32.62
  • AXR 59.55
  • Support Level
  • SLDB $5.39
  • AXR $30.04
  • Resistance Level
  • SLDB $6.19
  • AXR $32.05
  • Average True Range (ATR)
  • SLDB 0.39
  • AXR 1.74
  • MACD
  • SLDB -0.02
  • AXR 0.20
  • Stochastic Oscillator
  • SLDB 2.00
  • AXR 52.97

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve the obtaining of approvals and the sale of both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

Share on Social Networks: